Further research is needed to confirm this phenomenon, but our results, although preliminary, are of great importance as they constitute the first attempt to assess the relationship between two important pathogenetic pathways resulting from MMP-2 and RhoA activation, leading to ischemia and reperfusion damage to the heart muscle. The gene discussed is RHOA; the disease is ischemia.